Clinical trials
Recruiting Hyperlipoproteinemia Type II trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Verve Therapeutics, Inc. | 2 |
| Arrowhead Pharmaceuticals | 1 |
| Institut de Recherches Cliniques de Montreal | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 6 |
| Coronary Artery Disease | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Homozygous Familial Hypercholesterolemia | 1 |
| Hypercholesterolemia | 1 |
| Hyperlipidemias | 1 |
| Hypertriglyceridemia | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
| Lipid Metabolism Disorders | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.